Other languages Takeda Pharmaceutical Company Limited Deutsche Boerse AG

Equities

TKDA

US8740602052

Real-time Estimate Tradegate Other stock markets 11:05:18 2024-06-17 EDT			5-day change	1st Jan Change
12.25 ^EUR	+2.08%		-2.44%	-4.76%

03:35pm	Ovid Therapeutics Shares Slide Premarket After Takeda's Soticlestat Setback	DJ
03:21pm	Sector Update: Health Care Stocks Decline Premarket Monday	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Decline Premarket Monday	09:21am
Ovid Seeks Distance From Epilepsy Drug After Takeda Reports Phase 3 Endpoints Missed -- Pre-Bell Shares Fall	08:13am
Takeda Says Phase 3 Soticlestat Trials in Dravet, Lennox-Gastaut Syndromes Missed Primary Endpoints	08:00am
Takeda's seizure drug fails to meet main goal in late-stage studies	07:07am
Takeda Pharmaceutical Company Limited Announces Topline Data from its Phase 3 SKYLINE and SKYWAY Studies Evaluating Soticlestat for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome	06:55am
Takeda Announces Phase 3 Topline Results for Soticlestat in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome	06:45am
Takeda Signs Option Agreement with Ascentage to License Leukemia Drug	06-14
Takeda Pharmaceutical Company Limited Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, Third-Generation BCR-ABL Tyrosine Kinase Inhibitor	06-14
Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema	06-06
Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India	06-06
Takeda Pharmaceutical, Pfizer Say Phase 3 Trial Assessing Blood Cancer Combination Therapy Met Co-Primary Endpoints	06-03
Takeda Says Narcolepsy Drug Meets Main, Secondary Goals in Trial	06-03
Takeda Pharmaceutical Company Limited to Present Positive Results from its Phase 2B Trial of TAK-861	06-03
GSK blood cancer drug nearly halves risk of death in late-stage trial	06-02
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma	06-01
Takeda Pharmaceutical Says Recombinant ADAMTS13 Gets Approval Recommendation From European Medicines Agency's CHPM	05-31
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura	05-31
Pharmakonzern Takeda plant Abbau von bis zu 120 Stellen in Opfikon	05-31
BHP pursuit of Anglo American highlights corporate-led UK M&A upswing	05-30
Evotec steigt aus Gentherapie-Geschäft aus - Ergebniseinbruch zum Jahresstart	05-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Takeda Pharmaceutical Company Limited Deutsche Boerse AG

Equities

TKDA

US8740602052

Other languages

Filters